Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease

作者: Martin Hajsl , Alzbeta Hlavackova , Karolina Broulikova , Martin Sramek , Martin Maly

DOI: 10.3390/METABO10050208

关键词:

摘要: Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation immune response having together with oxidative stress (OS) significant effects on each phase atherosclerosis. The aim the study to analyze relationship plasma levels TRP metabolites, inflammation, OS patients neurovascular diseases (acute stroke (AIS), carotid artery stenosis (SCAS)) healthy controls. Blood samples were collected from 43 (25 SCAS, 18 AIS) 25 concentrations twelve riboflavin, neopterin (NEO, marker inflammation), malondialdehyde (MDA, OS) measured by liquid chromatography–tandem mass spectrometry (LC-MS/MS). Concentrations seven metabolites (TRP, kynurenine (KYN), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), anthranilic (AA), melatonin (MEL), tryptamine (TA)), NEO, MDA significantly different studied groups. Significantly lower TRP, KYN, 3-HAA, MEL, TA, higher found AIS compared SCAS patients. concentration both group (p < 0.001, p = 0.004, respectively) controls, NEO enhanced 0.003) AIS. did not directly correlate groups, except for 1) negative correlation 2) activity aminotransferase (r −0.552, 0.018; r −0.504, 0.033, respectively). In summary, metabolism clearly more deregulated patients; effect should be further elucidated.

参考文章(63)
Simon N. Young, Serge Gauthier, Tryptophan Availability and the Control of 5-Hydroxytryptamine and Tryptamine Synthesis in Human CNS Advances in Experimental Medicine and Biology. ,vol. 133, pp. 221- 230 ,(1981) , 10.1007/978-1-4684-3860-4_12
Daniela Krause, Hyeon-Sook Suh, Leonid Tarassishin, Qiao Ling Cui, Bryce A. Durafourt, Namjong Choi, Avital Bauman, Melissa Cosenza-Nashat, Jack P. Antel, Meng-Liang Zhao, Sunhee C. Lee, The Tryptophan Metabolite 3-Hydroxyanthranilic Acid Plays Anti-Inflammatory and Neuroprotective Roles During Inflammation The American Journal of Pathology. ,vol. 179, pp. 1360- 1372 ,(2011) , 10.1016/J.AJPATH.2011.05.048
Shinsuke Fukui, Robert Schwarcz, Stanley I. Rapoport, Yoshiaki Takada, Quentin R. Smith, Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism Journal of Neurochemistry. ,vol. 56, pp. 2007- 2017 ,(1991) , 10.1111/J.1471-4159.1991.TB03460.X
Guilhian Leipnitz, Cristiana Schumacher, Karina B. Dalcin, Karina Scussiato, Alexandre Solano, Cláudia Funchal, Carlos S. Dutra-Filho, Angela T.S. Wyse, Clóvis M.D. Wannmacher, Alexandra Latini, Moacir Wajner, In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochemistry International. ,vol. 50, pp. 83- 94 ,(2007) , 10.1016/J.NEUINT.2006.04.017
Lucile Capuron, Simon Geisler, Katharina Kurz, Friedrich Leblhuber, Barbara Sperner-Unterweger, Dietmar Fuchs, Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism Current Pharmaceutical Design. ,vol. 20, pp. 6048- 6057 ,(2014) , 10.2174/1381612820666140317110217
Wentao Zhu, Axel P. Stevens, Katja Dettmer, Eva Gottfried, Sabine Hoves, Marina Kreutz, Ernst Holler, André B. Canelas, Ido Kema, Peter J. Oefner, Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography–tandem mass spectrometry Analytical and Bioanalytical Chemistry. ,vol. 401, pp. 3249- 3261 ,(2011) , 10.1007/S00216-011-5436-Y
Ah Siew Sim, Chris Salonikas, Daya Naidoo, David Emil Leon Wilcken, Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. Journal of Chromatography B. ,vol. 785, pp. 337- 344 ,(2003) , 10.1016/S1570-0232(02)00956-X
A Sakotnik, Decreased melatonin synthesis in patients with coronary artery disease. European Heart Journal. ,vol. 20, pp. 1314- 1317 ,(1999) , 10.1053/EUHJ.1999.1527